Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


TCT 2016: EXCEL And NOBLE Give Different Answers On Stenting Vs. Surgery For Left-Main Disease

Executive Summary

NOBLE found that the five-year risk of major adverse events was higher after stenting compared to coronary bypass surgery to treat unprotected left-main coronary artery disease, while EXCEL found that stenting is safer than surgery in patients with this condition and low anatomic complexity.


Related Content

TCT 2017: PCI And CABG Yield Similar QOL Outcomes For Left-Main Disease


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts